Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 May;49(5):663–667. doi: 10.1038/bjc.1984.103

Pregnancy-specific beta 1-glycoprotein (SP1) in serum and tissue from patients with benign and malignant breast tumours.

S Sørensen, J Andersen, T Nørgaard
PMCID: PMC1976724  PMID: 6609709

Full text

PDF
663

Images in this article

665Figure 3
on p.665

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen K. W., Mouridsen H. T., Castberg T., Fischerman K., Andersen J., Hou-Jensen K., Brincker H., Johansen H., Henriksen E., Rørth M. Organisation of the Danish adjuvant trials in breast cancer. Dan Med Bull. 1981 Aug;28(3):102–106. [PubMed] [Google Scholar]
  2. Grudzinskas J. G., Coombes R. C., Ratcliffe J. G., Gordon Y. B., Powles T. J., Neville A. M., Chard T. Circulating levels of pregnancy specific beta 1 glycopretein in patients with testicular, bronchogenic and breast carcinomas. Cancer. 1980 Jan 1;45(1):102–103. doi: 10.1002/1097-0142(19800101)45:1<102::aid-cncr2820450118>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  3. Heyderman E. Immunoperoxidase technique in histopathology: applications, methods, and controls. J Clin Pathol. 1979 Oct;32(10):971–978. doi: 10.1136/jcp.32.10.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Horne C. H., Reid I. N., Milne G. D. Prognostic significance of inappropriate production of pregnancy proteins by breast cancers. Lancet. 1976 Aug 7;2(7980):279–282. doi: 10.1016/s0140-6736(76)90731-5. [DOI] [PubMed] [Google Scholar]
  5. Hunter W. M., Bennie J. G. Reduction of non-specific serum responses in human pituitary gonadotrophin radioimmunoassays. J Endocrinol. 1979 Jan;80(1):59–68. doi: 10.1677/joe.0.0800059. [DOI] [PubMed] [Google Scholar]
  6. Inaba N., Renk T., Wurster K., Rapp W., Bohn H. Ectopic synthesis of pregnancy specific beta 1-glycoprotein (SP1) and placental specific tissue proteins (PP5, PP10, PP11, PP12) in nontrophoblastic malignant tumours. Possible markers in oncology. Klin Wochenschr. 1980 Aug 1;58(15):789–791. doi: 10.1007/BF01478287. [DOI] [PubMed] [Google Scholar]
  7. Kaminska J., Calvert I., Rosen S. W. Radioimmunoassay of "pregnancy-specific"-beta 1-glycoprotein (SP1). Clin Chem. 1979 Apr;25(4):577–580. [PubMed] [Google Scholar]
  8. Rosen S. W., Gail M. H., Tormey D. C. Use of circulating pregnancy-specific beta 1 glycoprotein as a marker in carcinoma of the breast in women. J Natl Cancer Inst. 1982 Nov;69(5):1067–1071. [PubMed] [Google Scholar]
  9. Searle F., Leake B. A., Bagshawe K. D., Dent J. Serum-SP1-pregnancy-specific-beta-glycoprotein in choriocarcinoma and other neoplastic disease. Lancet. 1978 Mar 18;1(8064):579–581. doi: 10.1016/s0140-6736(78)91027-9. [DOI] [PubMed] [Google Scholar]
  10. Sørensen S., Trentemøller S. Purification of the major component of the pregnancy-specific beta 1-glycoprotein (SP1) by affinity chromatography, and application to a highly sensitive radioimmunoassay. Oncodev Biol Med. 1983;4(5):351–361. [PubMed] [Google Scholar]
  11. Tatarinov Y. S. The diagnostic value of circulating trophoblast-specific beta 1-glycoprotein (TSG) in cancer patients. Br J Cancer. 1980 May;41(5):821–824. doi: 10.1038/bjc.1980.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Walker R. A. Differentiation of human breast carcinomas: an immunohistological study of appropriate and inappropriate protein production. J Pathol. 1981 Sep;135(1):87–95. doi: 10.1002/path.1711350106. [DOI] [PubMed] [Google Scholar]
  13. Würz H. Serum concentrations of SP1 (pregnancy-specific-beta1-glycoprotein) in healthy, nonpregnant individuals, and in patients with nontrophoblastic malignant neoplasms. Arch Gynecol. 1979 Mar 28;227(1):1–6. doi: 10.1007/BF02108622. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES